← All diseases Liver, kidneys and digestion

Liver cirrhosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest Quality Evidence Only (112)Meta-analysis (33)Treatment guideline (8)Randomized trial (33)Systematic review (22)Phase 3 study (16)Clinical trial (635)Review article (465)Early study (phase 1 or 2) (8)Laboratory or animal research (168)Case report (153)Commentary or editorial (44)Retracted Publication (4) Studies Currently Seeking Participants Only (38)

Filter

Publications and studies (3127)

• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A three-year review (2023-2025) on the effectiveness of natural products from plants in treating major types of fibrosis. (2025/11/25) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Huangjia Ruangan granules with entecavir for fibrosis regression in Chronic Hepatitis B: A multicenter, randomized, double-blind, phase II trial. (2025/11/25) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Effects of Abrus cantoniensis capsule on gut microbiota and intestinal barrier in mice infected with alveolar echinococcosis. (2025/11/25) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. [PNPLA3 gene I148M polymorphism induces hepatic fibrosis via cholesterol metabolic dysregulation in mice]. (2025/11/25) ♡
• Association Between Liver Function Grade and Post-Hepatectomy Liver Failure in Patients With Hepatocellular Carcinoma: A Latent Class Analysis. (2025/11/25) ♡
• Effects of a Bioactive Vegetable-Enriched Diet on Autotaxin and Liver Fibrosis in MASLD with Evidence of Sex-Specific Responses: A Pilot Study. (2025/11/24) ♡
• Comparison of the Effectiveness of Nutritional Risk Score-2002 and Royal Free Hospital-Nutritional Prioritizing Tool Nutrition Screening Tools in Liver Cirrhosis. (2025/11/21) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Optimal Timing of Endoscopic Intervention for Acute Variceal Bleeding in Cirrhotic Patients: A Systematic Review and Meta-Analysis. (2025/11/21) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [A review of research progress in integrated traditional Chinese and Western Medicine for liver diseases]. (2025/11/20) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Close multilevel links between metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus. (2025/11/20) ♡
• Carvedilol decreases hepatic vascular resistance by reducing fibrogenesis and reversing endothelial dysfunction in cirrhotic rats. (2025/11/20) ♡
• Plasma exchange as potential treatment of severe immune checkpoint inhibitor-induced hepatitis. (2025/11/20) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Metabolic dysfunction-associated steatotic liver disease in prison populations: a review of its impact and current and future challenges. (2025/11/18) ♡
• Agrimoniin ameliorates intrapulmonary angiogenesis and improves hypoxemia in hepatopulmonary syndrome via PGC-1α activation and glycolysis down-regulation. (2025/11/18) ♡
• Longitudinal risk of cirrhosis by steatotic liver disease subtype among 1.5 million individuals in the US. (2025/11/15) ♡
• Hepatotoxicity Prediction and Multi-omics Reveal Mitochondrial and Lipid Metabolic Dysregulation in PM(2.5)-Induced Liver Fibrosis. (2025/11/14) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Effect of Multidisciplinary Team-Based Refined Nursing on Outcomes in Elderly Patients with Liver Cirrhosis and Upper Gastrointestinal Bleeding. (2025/11/11) ♡
• Soluble urokinase plasminogen activator receptor is a prognostic biomarker in decompensated cirrhosis. (2025/11/11) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Successful Use of Midodrine in a Normotensive, Non-cirrhotic Patient With Chylous Ascites Due to Chronic Porto-Mesenteric Thrombosis: A Multidisciplinary Challenge. (2025/11/07) ♡
• Circulating miRNAs combined with AFP improve diagnostic accuracy for HBV-associated hepatocellular carcinoma. (2025/11/06) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Metabolic dysregulation in MASLD-associated HCC: diagnostic biomarkers and therapeutic opportunities. (2025/11/04) ♡
• Prevalence of metabolic dysfunction-associated steatotic liver disease and fibrosis defined by liver elastography in the United States using National Health and Nutrition Examination Survey 2017-March 2020 and August 2021-August 2023 data. (2025/11/01) ♡
• Quercetin and Camellia sinensis leaf extract ameliorates liver steatosis in high-fat diet fed mice via suppression of oxidative stress and inflammation. (2025/11/01) ♡
• Treatment With Resmetirom for Up to 2 Years Led to Improvement in Liver Stiffness, Fibrosis Biomarkers, Fibrosis Scores, and Portal Hypertension Risk in 122 Patients With Compensated MASH Cirrhosis. (2025/11/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) in Children - A Review For Primary Care Pediatrics. (2025/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Case of Sudden Unexplained Death in Alcohol Misuse in a 49-Year-Old Woman. (2025/10/31) ♡
• Knowledge, attitude, and practice toward antiviral treatment of chronic hepatitis B among patients. (2025/10/28) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: A novel approach to pseudoportomesenteric hypertension with refractory chylothorax and ascites. (2025/10/27) ♡
• [Diagnostic value of serum Mac-2 binding protein for the severity of schistosomiasis-induced liver fibrosis]. (2025/10/27) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A National Multicenter Study on Initial Antiviral Treatment Preferences on Chronic Hepatitis B: Entecavir Versus Tenofovir Disoproxil Fumarate. (2025/10/23) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diabetes and NAFLD: A Synergistic Threat to Metabolic Health. (2025/10/18) ♡
• Bioinformatics based exploration of the anti-liver fibrosis mechanism of Pien Tze Huang via EGFR/JAK1/STAT3 pathway. (2025/10/17) ♡
• Hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease with increased alcohol intake (MetALD). (2025/10/16) ♡
• Imbalance of the Immune Response According to Alcohol Consumption Patterns. (2025/10/16) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. High Index of Suspicion Has Life-Changing Results in an Older Adult Patient. (2025/10/13) ♡
• Application of a novel endoscopic ultrasound-guided motorized fine needle for liver and pancreatic lesion biopsy. (2025/10/11) ♡
• Lactococcus A phages predict ACLF while Enterococcus B phages predict bacterial infection in decompensated cirrhosis. (2025/10/10) ♡
• Orphan drug uttroside B impedes MASH progression and HCC development in experimental models. (2025/10/10) ♡
• Indocyanine Green Retention Rate at 15 Minutes as a Key Predictor of Clinically Significant Portal Hypertension in Cirrhosis: Development and Validation of a Superior Non-Invasive Diagnostic Model. (2025/10/10) ♡
• 3D endothelial cell scaffolds protect liver explants and exhibit therapeutic effects on liver fibrosis. (2025/10/04) ♡
• Histopathological Features and Antiviral Efficacy in Patients Over 30 Years Old with Chronic Hepatitis B in the Indeterminate Phase. (2025/10/03) ♡
• Integration of network pharmacology, transcriptomics and single-cell sequencing to explore the effect of Rougan Keli in alleviating liver cirrhosis. (2025/10/02) ♡
• Natural small molecule hinokitone mitigates NASH fibrosis by targeting regulation of FXR-mediated hepatocyte apoptosis. (2025/10/01) ♡
• Frailty in children with chronic liver disease: Prevalence and impact on outcomes. (2025/10/01) ♡
• Crosstalk Between Long Non-coding RNA MALAT1, miRNA-181a, and IL-17 in Cirrhotic Patients and Their Possible Correlation SIRT1/NF-Ƙβ Axis. (2025/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Clinical aspects encountered in patients with portopulmonary hypertension. (2025/10/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Re: 'Safety and immunogenicity of hepatitis E vaccine in compensated liver cirrhosis with chronic hepatitis B' by Liao et al. (2025/10/01) ♡
• The Relationship between Carotid Artery Stenosis and the Severity of Fatty Liver in Patients with Coronary Artery Disease Who Are Candidates for Angiography. (2025/10/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [TIPS dysfunction: what has to be done?]. (2025/09/30) ♡
• Pre-emptive TIPS should be considered in high-risk patients with both acute variceal bleeding and severe alcohol-related hepatitis. (2025/09/29) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.